SPIEGELMAN DANIEL K 4

What Happened
Daniel K. Spiegelman, a director of vTv Therapeutics Inc. (VTVT), was granted a derivative award on 2026-06-26 covering 6,000 shares with an implied value of $35.08 per share, for a total of $210,480. This transaction is recorded as an award/grant (derivative), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-26; Form 4 filed: 2026-06-29 (appears timely).
• Security/amount: derivative award for 6,000 shares at $35.08 per share; total reported value $210,480.
• Vesting: The award vests on the earlier of June 26, 2027 or the date of the 2027 annual general meeting, subject to continued board service.
• Shares owned after transaction: Not reported in the provided filing data.
• Transaction code: A (grant/award/other acquisition). No 10b5-1, tax-withholding, or cashless exercise noted in the provided information.

Context
This was a grant of a derivative equity award (likely stock options or restricted stock units) that vests with continued service — it does not indicate an immediate market purchase or sale. Such grants are common for directors as compensation and do not by themselves signal a buy/sell decision; vesting and exercise/sale behavior later would be more informative.